Automated Clinical Chemistry Analyser

Tender description

The Biomedical Sciences Research Institute at Ulster University is a centre of excellence for pioneering research into the mechanisms behind human degenerative disease. Our Research Groups focus on: Diabetes; Food & Health; Genomic Medicine; Pharmaceutical Science & Practice; Stratified Medicine; and Optometry. Multi-disciplinary collaboration results in research into, for instance, anti-diabetic and anti-oncogenic aspects of nutrition, the genomics of vitamin receptors and cancer, and the interactions among diet, diabetes, dementia, vision, hypertension and vascular disease. There is a need to supply an automated clinical analyser as a replacement for the currently-used analyser, an I-Lab 650. We require an instrument of comparable or higher specification, capable of performing both the commercial assays and the in-house developed tests currently performed in BMSRI. Performance Analysis: The instrument must perform spectrophotometric and immunoturbidimetric assays with end-point and kinetic analysis and permit the use of multiple calibrators. The system must be able to function reliably with multiple matrices, including but not limited to: blood and blood products, cell supernatants, urine, breast milk and faecal water, in human and animal models. All human analytes must be reliably quantified in the clinically-relevant range. The instrument should provide at least 50 channels, of which 15 must be open for flexible programming. It must allow multiple reagent additions and extended reaction/incubation times, and permit access to raw OD data. It must flag results outside analytical range, linearity failures, substrate exhaustion and noise errors. It must offer on-board pre-dilution of samples and user-configurable automatic re-run (e.g., when outside analytical range). The system must provide an on-board log for calibration and QC data, and permit review of these data. Proof must be provided of multi-lab validation for commercially available